celastrol methyl ester has been researched along with Inflammation in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chan, WK; Chang, MN; He, W; Huang, FC; Moriarty, KJ; Yu, KT; Zhang, DC; Zilberstein, A | 1 |
Cao, Y; Chen, L; He, C; Huang, D; Luo, X; Peng, J; Su, L; Yang, F | 1 |
Bi, Y; Guo, J; Liu, YX; Pan, LR; Tan, Y; Yu, XJ; Zhao, Q; Zhong, J | 1 |
3 other study(ies) available for celastrol methyl ester and Inflammation
Article | Year |
---|---|
Novel cytokine release inhibitors. Part I: Triterpenes.
Topics: Animals; Cytokines; Humans; In Vitro Techniques; Inflammation; Molecular Structure; Rats; Triterpenes | 1998 |
Pristimerin alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease via inhibiting NF-κB pathway.
Topics: Animals; Cigarette Smoking; Humans; Inflammation; Lung; Mice; NF-kappa B; Nicotiana; Pentacyclic Triterpenes; Pulmonary Disease, Chronic Obstructive | 2022 |
Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Inflammasomes; Inflammation; Lipopolysaccharides; Liver; Male; Metabolic Diseases; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Peritonitis; Uric Acid | 2021 |